SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026306
Filing Date
2021-05-11
Accepted
2021-05-11 08:15:35
Documents
77
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-10q_20210331.htm 10-Q 1520125
2 EX-31.1 hrmy-ex311_379.htm EX-31.1 20681
3 EX-31.2 hrmy-ex312_380.htm EX-31.2 21160
4 EX-32.1 hrmy-ex321_377.htm EX-32.1 10713
5 EX-32.2 hrmy-ex322_378.htm EX-32.2 10624
  Complete submission text file 0001564590-21-026306.txt   6130106

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrmy-20210331.xml EX-101.INS 1142850
7 XBRL TAXONOMY EXTENSION SCHEMA hrmy-20210331.xsd EX-101.SCH 59661
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrmy-20210331_cal.xml EX-101.CAL 56978
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrmy-20210331_def.xml EX-101.DEF 190243
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrmy-20210331_lab.xml EX-101.LAB 416403
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrmy-20210331_pre.xml EX-101.PRE 348769
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 21909714
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences